Glooko announces Presidents of Life Sciences and Connected Care

David Pass and Adam Hameed bring decades of business development, strategy, and industry experience to Glooko’s leadership team

Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma and medical partners, proudly announces the appointments of Dr. David Pass and Adam Hameed as Presidents of Life Sciences and Connected Care, respectively.

By establishing these new roles, Glooko is positioning itself for continued growth and innovation in chronic condition management. With the evolving landscape of healthcare technology and increasing demand for personalized care, these new roles underscore Glooko’s commitment to driving advancements not only in health systems, but also across the life sciences space, specifically: digital companions/therapeutics, clinical research, real-world data and device integrations.

Dr. Pass joins Glooko as President of Life Sciences with extensive experience in pharmaceuticals, medical devices, and healthcare technology. With over 25 years of commercial and business leadership, his deep therapeutic experience in chronic conditions such as Type 2 Diabetes, Obesity, and Cardiovascular Disease, will help further accelerate Glooko’s growth in Life Sciences. Meanwhile, Mr. Hameed assumes the role of President of Connected Care, leveraging his strong background in healthcare technology and growth strategy. Mr. Hameed assumes a pivotal role in advancing the Connected Care growth strategy, focusing on global sales and account management.

“We are thrilled to welcome David and Adam as Presidents of Life Sciences and Connected Care,” said Russ Johannesson, CEO of Glooko. “With David and Adam leading our market facing strategies for these differentiated business units, we are confident that their unique experience and close collaboration will help Glooko drive significant new value for our customers, users and partners globally.”

In his previous roles, Dr. Pass served as Chief Operating Officer and Chief Commercial Officer at Gelesis and Vice President of Marketing at Boehringer Ingelheim (BI) for Diabetes, where he built a multi-billion dollar franchise and led the BI alliance with Eli Lilly & Company. Mr. Hameed brings a strong commercial strategy background from Andros, where he served as Chief Growth Officer, and Cricket Health (now part of Interwell Health), where he served as Chief Development Officer. Prior to that, Mr. Hameed held key leadership positions at Optum, where he led Payer Sales and Account Management for OptumHealth as well as several go-to-market teams for OptumInsight.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

Related posts

Mirth Connect Receives ONC Health IT Cures Update Certification

Business Wire

Medical Device Co. Presidio Medical Appoints New Executive

Business Wire

NCCN and Flatiron Health announce collaboration

Business Wire